US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Magenta Therapeutics Inc (MGTA)
Magenta Therapeutics Inc (MGTA) ニュース

MGTA

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MGTA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/17	05 : 10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/09/17	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/09/13	09 : 45	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/08/09	05 : 26	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/08/09	05 : 21	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/08/09	05 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/08/09	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/06/06	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	09 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	09 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	09 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	09 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	08 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	08 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	08 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	06 : 24	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/29	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/10	05 : 27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/10	05 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/10	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05 : 10	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05 : 09	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/02	07 : 34	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/02	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/28	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	06 : 10	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	06 : 02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	05 : 07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	05 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:MGTA

1 2 3 4 5 6 7 8 9 10 次へ >>

Sterling vs KWD

DAXsector All Media Kurs

Vontobel Financial Produ...

Brazil Realty Fundo Inve...

FT Vest US Equity Buffer...

Fidelity International V...

Prominence Energy NL

Tyranna Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約